NasdaqCM - Delayed Quote USD

Anebulo Pharmaceuticals, Inc. (ANEB)

1.3900
+0.1200
+(9.45%)
At close: June 13 at 4:00:02 PM EDT
1.3900
+0.12
+(9.45%)
After hours: June 13 at 4:00:02 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
0
0
0
0
0
Operating Expense
7,450.2930
8,308.7550
11,783.5990
6,831.1740
3,613.7530
Operating Income
-7,450.2930
-8,308.7550
-11,783.5990
-6,831.1740
-3,613.7530
Net Non Operating Interest Income Expense
-238.7230
97.7920
92.4070
7.3320
-10.7470
Other Income Expense
-0.8880
9.2600
-41.1460
-1.7770
-26,628.0540
Pretax Income
-7,689.9040
-8,201.7030
-11,732.3380
-6,825.6190
-30,252.5540
Net Income Common Stockholders
-7,689.9040
-8,201.7030
-11,732.3380
-6,825.6190
-38,460.9470
Diluted NI Available to Com Stockholders
-7,689.9040
-8,201.7030
-11,732.3380
-6,825.6190
-38,460.9470
Basic EPS
-0.25
-0.32
-0.47
-0.29
-2.83
Diluted EPS
-0.25
-0.32
-0.47
-0.29
-2.83
Basic Average Shares
30,039.3700
25,822.2580
25,074.4810
23,344.5670
13,612.7010
Diluted Average Shares
30,039.3700
25,822.2580
25,074.4810
23,344.5670
13,612.7010
Total Operating Income as Reported
-8,232.9640
-8,308.7550
-11,783.5990
-6,831.1740
-3,613.7530
Total Expenses
7,450.2930
8,308.7550
11,783.5990
6,831.1740
3,613.7530
Net Income from Continuing & Discontinued Operation
-7,689.9040
-8,201.7030
-11,732.3380
-6,825.6190
-30,252.5540
Normalized Income
-7,689.9040
-8,201.7030
-11,732.3380
-6,825.6190
-3,625.8440
Interest Income
185.5480
249.0220
92.4070
7.3320
1.0200
Interest Expense
424.2710
151.2300
0
0
11.7670
Net Interest Income
-238.7230
97.7920
92.4070
7.3320
-10.7470
EBIT
-7,265.6330
-8,050.4730
-11,732.3380
-6,831.1740
-30,240.7870
EBITDA
-7,265.6330
-8,050.4730
-11,732.3380
-6,831.1740
-30,240.7870
Net Income from Continuing Operation Net Minority Interest
-7,689.9040
-8,201.7030
-11,732.3380
-6,825.6190
-30,252.5540
Total Unusual Items Excluding Goodwill
--
--
--
--
-26,626.7100
Total Unusual Items
--
--
--
--
-26,626.7100
Normalized EBITDA
-7,265.6330
-8,050.4730
-11,732.3380
-6,831.1740
-3,614.0770
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
6/30/2021 - 5/7/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ACXP Acurx Pharmaceuticals, Inc.
0.3050
-7.60%
 
6VX.F Healios K.K.
3.0000
+2.74%
 
SABS SAB Biotherapeutics, Inc.
1.7100
-6.61%
 
CRGX CARGO Therapeutics, Inc.
4.3900
-2.01%
 
ANTX AN2 Therapeutics, Inc.
1.0700
-5.31%
 
NURL.CN NeuralThera
0.0300
+20.00%
 
GDTC CytoMed Therapeutics Limited
2.0800
-2.58%
 
TSBX Turnstone Biologics Corp.
0.3345
-6.22%
 
BRNS Barinthus Biotherapeutics plc
0.9033
-3.27%
 
IKT Inhibikase Therapeutics, Inc.
1.8600
-2.62%